World Journal of Oncology, ISSN 1920-4531 print, 1920-454X online, Open Access
Article copyright, the authors; Journal compilation copyright, World J Oncol and Elmer Press Inc
Journal website http://www.wjon.org

Original Article

Volume 8, Number 5, October 2017, pages 147-150


Metastatic Malignant Thymoma to the Abdomen: A SEER Database Review and Assessment of Treatment Strategies

Figures

Figure 1.
Figure 1. Incidence of malignant thymoma cases from 1973 to 2008 using data from the SEER database.
Figure 2.
Figure 2. Incidence of malignant thymomas by gender from 1973 to 2008 using data from the SEER database.

Table

Table 1. Review of the 15 Cases of Extrathoracic Metastasis to the Abdomen Over the Last 60 Years That Provided Treatment Information
 
TreatmentsSize and locationDFI (months)Survival (months)Symptoms
Characteristics of the tumor, treatment modality, DFI, survival, and presence of additional symptoms are recorded. DFI: disease-free interval; survival based on time from metastasis to death; SM: symptoms of metastasis.
Surgery and chemotherapy (1)13 × 12 cm
Liver
122040/1
Surgery, chemotherapy and radiation (8)0.15 - 18 cm
Kidney, gastrointestinal tract (4), liver (3), bladder, ovary (2), perisplenic, retroperitonium
59.928.34/8
Surgery alone (2)4.57 cm
Liver (2), gastrointestinal tract, spleen
3.9NA1/2
Chemotherapy alone (1)NA
Liver, kidney
NANA1/1
Radiotherapy alone (2)NA
Liver (2), gastrointestinal tract (2)
1564710/2
Chemotherapy and radiotherapy (1)NA
Liver
501/1